Global Adiposity and Thickness of Intraperitoneal and Mesenteric Adipose Tissue Depots Are Increased in Women With Polycystic Ovary Syndrome

    Susana Borruel, Elena Fernández-Durán, Macarena Alpañés, David Martí Sánchez, Francisco Álvarez-Blasco, Manuel Luque-Ramírez, Héctor F. Escobar-Morreale
    Image of study
    TLDR Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.
    In a study conducted at an academic hospital, researchers examined the distribution of body fat in 55 women with polycystic ovary syndrome (PCOS), 25 control women, and 26 men with similar body mass index (BMI). Using ultrasound measurements and a body fat monitor, the study found that women with PCOS had increased total body fat and specifically greater thickness of intraperitoneal and mesenteric fat compared to control women, with values that were intermediate between control women and men. The study also noted that obesity increased the thickness of adipose tissue depots across all groups. Additionally, women with PCOS had higher fat mass as a percentage of total body mass, higher hirsutism scores, higher levels of total and free testosterone, higher fasting insulin levels, lower insulin sensitivity, lower HDL-cholesterol, and higher LDL-cholesterol and triglycerides compared to control women and men. The differences in adipose tissue thickness were independent of obesity, and no differences in hepatic steatosis were observed among the groups, although it was more prevalent in obese subjects. Adipose tissue thickness also correlated with various clinical, hormonal, and metabolic variables.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 2 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  445 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 5 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Similar Research

    5 / 1000+ results